Trexquant Investment LP United Therapeutics Corp Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

A detailed history of Trexquant Investment LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Trexquant Investment LP holds 2,973 shares of UTHR stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,973
Holding current value
$1.07 Million
% of portfolio
0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$311.04 - $363.55 $924,721 - $1.08 Million
2,973 New
2,973 $1.07 Million
Q1 2024

May 14, 2024
BUY
$210.76 - $249.51 $2.32 Million - $2.74 Million
10,990 Added 55.49%
30,796 $7.07 Million
Q4 2023

Feb 09, 2024
BUY
$214.88 - $256.94 $1.24 Million - $1.48 Million
5,770 Added 41.11%
19,806 $4.36 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $2.97 Million - $3.48 Million
14,036 New
14,036 $3.17 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $2.23 Million - $2.9 Million
10,493 New
10,493 $2.35 Million
Q2 2022

Aug 11, 2022
SELL
$174.81 - $241.14 $59,435 - $81,987
-340 Reduced 7.17%
4,402 $1.04 Million
Q1 2022

May 13, 2022
BUY
$166.16 - $213.96 $355,083 - $457,232
2,137 Added 82.03%
4,742 $851,000
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $553,328 - $648,672
-3,002 Reduced 53.54%
2,605 $563,000
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $1.01 Million - $1.2 Million
5,607 New
5,607 $1.04 Million
Q4 2020

Feb 11, 2021
SELL
$101.87 - $151.79 $1.14 Million - $1.7 Million
-11,174 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$99.9 - $121.13 $936,063 - $1.13 Million
9,370 Added 519.4%
11,174 $1.13 Million
Q2 2020

Aug 07, 2020
SELL
$92.74 - $125.82 $924,432 - $1.25 Million
-9,968 Reduced 84.68%
1,804 $218,000
Q1 2020

May 08, 2020
SELL
$79.39 - $115.35 $465,146 - $675,835
-5,859 Reduced 33.23%
11,772 $1.12 Million
Q4 2019

Feb 12, 2020
SELL
$78.31 - $95.34 $24,902 - $30,318
-318 Reduced 1.77%
17,631 $1.55 Million
Q3 2019

Nov 08, 2019
SELL
$74.85 - $85.99 $2.43 Million - $2.79 Million
-32,471 Reduced 64.4%
17,949 $1.43 Million
Q2 2019

Aug 09, 2019
BUY
$76.06 - $120.81 $3.83 Million - $6.09 Million
50,420 New
50,420 $3.94 Million
Q4 2018

Feb 13, 2019
SELL
$101.4 - $128.73 $404,281 - $513,246
-3,987 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$113.81 - $129.46 $453,760 - $516,157
3,987 New
3,987 $510,000
Q2 2018

Aug 07, 2018
SELL
$101.14 - $118.31 $239,499 - $280,158
-2,368 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$107.21 - $151.94 $253,873 - $359,793
2,368 New
2,368 $266,000
Q4 2017

Feb 09, 2018
SELL
$118.58 - $151.28 $484,517 - $618,130
-4,086 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$114.6 - $136.81 $468,255 - $559,005
4,086
4,086 $479,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email